<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7438404\results\search\virus\results.xml">
  <result pre="viral entry inhibition against several enveloped viruses, such as the" exact="human immunodeficiency virus" post="(HIV). GRFT is capable of binding to terminal mannoses"/>
  <result pre="then optimized synthetically, generating mucroporin-M1, which was able to inhibit" exact="measles virus" post="(MeV), SARS-CoV, and influenza H5N1. Specifically, mucroporin M-1 affected"/>
  <result pre="Singapore491â€&quot;3. HuangI.-C.BoschB. J.LiF.LiW.LeeK. H.GhiranS.et al. (2006). SARS coronavirus, but not" exact="human coronavirus" post="NL63, utilizes cathepsin L to infect ACE2-expressing cells.J. Biol."/>
  <result pre="Agents Chemother.583354â€&quot;3359. 10.1128/AAC.02794-1324687509 PyrcK.BoschB. J.BerkhoutB.JebbinkM. F.DijkmanR.RottierP.et al. (2006). Inhibition of" exact="human coronavirus" post="NL63 infection at early stages of the replication cycle.Antimicrob."/>
  <result pre="RoquesP.ThibervilleS.-D.Dupuis-MaguiragaL.LumF.-M.LabadieK.MartinonF.et al. (2018). Paradoxical effect of chloroquine treatment in enhancing" exact="chikungunya virus" post="infection.Viruses10:268. 10.3390/v1005026829772762 RossignolJ.-F. (2014). Nitazoxanide: a first-in-class broad-spectrum antiviral"/>
  <result pre="E.ChanW. K. K.MorelandN. J.RathoreA. P.WangC.et al. (2013). Nuclear localization of" exact="dengue virus" post="(DENV) 1â€&quot;4 non-structural protein 5; protection against all 4"/>
 </snippets>
</snippetsTree>
